Introduction: Tirzepatide peptides present you with a dual GIP and GLP-1 receptor agonist action which has a five-day 50 %-lifetime enabling the moment-weekly dosing and excellent weight loss efficacy in clinical trials. In many weight-loss journeys, issues often compound: finding an effective treatment method with workable dosing frequency, guara